Integrity of active components of botanical products used in complementary and alternative medicine

JAMA

Volumn 300, Issue 17, 2008, Pages 1995-

  Stoney, Catherine M ^a   Coates, Paul ^a   Briggs, Josephine P ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERICUM PERFORATUM EXTRACT; PLANT EXTRACT;

ALTERNATIVE MEDICINE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; HUMAN; HYPERICUM PERFORATUM; LETTER; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; MEDICINAL PLANT; NATIONAL HEALTH INSURANCE; OXIDATION; PRIORITY JOURNAL; QUALITY CONTROL; DRUG STABILITY; NOTE; PHYTOTHERAPY; STANDARD;

COMPLEMENTARY THERAPIES; DRUG STABILITY; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 55549118225     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.557     Document Type: Letter

References (4)

1. Chan E. Quality of efficacy research in complementary and alternative medicine. JAMA. 2008;299(22):2685-2686.
2. Weber W, Vander Stoep A, McCarty RL, et al. Hypericum perforatum (St John's Wort) for attention-deficit/hyperactivity disorder in children and adolescents. JAMA. 2008;299(22):2633-2641.
3. Biologically active agents used in CAM and placebo materials: policy and guidance. National Center for Complementary and Alternative Medicine Web site. http://nccam.nih.gov/research/policies/bioactive.htm. Accessed August 14, 2008.
4. Betz JM, Fisher KD, Saldanha LG, Coates PM. The NIH analytical methods and reference materials program for dietary supplements. Anal Bioanal Chem. 2007;389(1):19-25.